ONO Pharmaceutical Co (4528N) Q2 2026 Earnings Report
MX:4528N Q2 2026 EPS Results
- Actual EPS
- MXN 5.27
- Consensus EPS
- MXN 5.19
- Beat/Miss
- Beat by +MXN 0.08
- One Year Ago EPS
- MXN 5.69
MX:4528N Q2 2026 Revenue Results
- Actual Revenue
- MXN 13.87B
- Expected Revenue
- MXN 13.67B
- Beat/Miss
- Beat by +MXN 201.55M
- YoY Revenue Growth
- -10.23%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 10/29/2026
- Time
- Before Open
- Conference Call
- Thursday, October 29, 2026
MX:4528N Upcoming Earnings
ONO Pharmaceutical Co's next earnings date is estimated for February 1, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:4528N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 01, 2027 | 2026 (Q3) | 5.58- | 7.32 | ― | ― |
| Oct 29, 2026 | 2026 (Q2) | 5.195.27 | 5.69 | -7.36% (-0.42) | |
| Jul 31, 2026 | 2026 (Q1) | 4.146.13 | 4.49 | 36.63% (+1.64) | |
| May 08, 2026 | 2025 (Q4) | 0.980.21 | -1.66 | 112.48% (+1.87) | |
| Feb 02, 2026 | 2025 (Q3) | 5.407.32 | 3.8 | 92.96% (+3.53) | |
| Oct 30, 2025 | 2025 (Q2) | 4.855.69 | 4.28 | 33.00% (+1.41) | |
| Aug 01, 2025 | 2025 (Q1) | 5.904.49 | 6.29 | -28.74% (-1.81) | |
| May 08, 2025 | 2024 (Q4) | 1.65-1.66 | 5.65 | -129.41% (-7.31) | |
| Feb 03, 2025 | 2024 (Q3) | 4.993.80 | 9.03 | -57.98% (-5.24) | |
| Oct 31, 2024 | 2024 (Q2) | 6.034.28 | 10.51 | -59.32% (-6.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
